Works matching IS 0167594X AND DT 2021 AND VI 153 AND IP 3


Results: 19
    1
    2
    3
    4
    5
    6
    7

    US Food and Drug Administration regulatory updates in neuro-oncology.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 375, doi. 10.1007/s11060-021-03789-5
    By:
    • Mehta, Gautam U.;
    • Barone, Amy K.;
    • Bradford, Diana;
    • Larkins, Erin;
    • Kim, Janice;
    • Pai-Scherf, Lee;
    • Jaigirdar, Adnan;
    • Shah, Mirat;
    • Wedam, Suparna;
    • Amiri-Kordestani, Laleh;
    • Theoret, Marc R.;
    • Pazdur, Richard;
    • Beaver, Julia A.;
    • Singh, Harpreet
    Publication type:
    Article
    8
    9
    10

    A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 487, doi. 10.1007/s11060-021-03786-8
    By:
    • Porper, Keren;
    • Shpatz, Yael;
    • Plotkin, Luba;
    • Pechthold, Ronit Goldman;
    • Talianski, Alisa;
    • Champ, Colin E.;
    • Furman, Orit;
    • Shimoni-Sebag, Ariel;
    • Symon, Zvi;
    • Amit, Uri;
    • Hemi, Rina;
    • Kanety, Hannah;
    • Mardor, Yael;
    • Cohen, Zvi R.;
    • Jan, Elisheva;
    • Genssin, Hili;
    • Anikster, Yair;
    • Zach, Leor;
    • Lawrence, Yaacov R.
    Publication type:
    Article
    11

    Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 479, doi. 10.1007/s11060-021-03784-w
    By:
    • Schäfer, Niklas;
    • Bumes, Elisabeth;
    • Eberle, Fabian;
    • Fox, Viola;
    • Gessler, Florian;
    • Giordano, Frank A.;
    • Konczalla, Juergen;
    • Onken, Julia;
    • Ottenhausen, Malte;
    • Scherer, Moritz;
    • Schneider, Matthias;
    • Vatter, Hartmut;
    • Herrlinger, Ulrich;
    • Schuss, Patrick
    Publication type:
    Article
    12
    13
    14
    15

    Combination chemotherapy versus temozolomide for patients with methylated MGMT (m-MGMT) glioblastoma: results of computational biological modeling to predict the magnitude of treatment benefit.

    Published in:
    Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 393, doi. 10.1007/s11060-021-03780-0
    By:
    • Castro, Michael;
    • Pampana, Anusha;
    • Alam, Aftab;
    • Parashar, Rajan;
    • Rajagopalan, Swaminathan;
    • Lala, Deepak Anil;
    • Roy, Kunal Ghosh Ghosh;
    • Basu, Sayani;
    • Prakash, Annapoorna;
    • Nair, Prashant;
    • Joseph, Vishwas;
    • Agarwal, Ashish;
    • G, Poornachandra;
    • Behura, Liptimayee;
    • Kulkarni, Shruthi;
    • Choudhary, Nikita Ray;
    • Kapoor, Shweta
    Publication type:
    Article
    16
    17
    18

    What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?

    Published in:
    Journal of Neuro-Oncology, 2021, v. 153, n. 3, p. 425, doi. 10.1007/s11060-021-03777-9
    By:
    • Adelon, Jihane;
    • Dufour, Christelle;
    • Foulon, Stéphanie;
    • Masliah Planchon, Julien;
    • Meyronnet, David;
    • Bourdeaut, Franck;
    • Palenzuela, Gilles;
    • Fouyssac, Fanny;
    • Raimbault, Sandra;
    • De Carli, Emilie;
    • Klein, Sébastien;
    • Pagnier, Anne;
    • Bertozzi, Anne-Isabelle;
    • Rome, Angélique;
    • David, Audrey;
    • Chabaud, Sylvie;
    • Faure-Conter, Cécile
    Publication type:
    Article
    19